To access this element change to forms mode OFF
Grant Award View - GA353550
Exploiting long noncoding RNAs for lung cancer diagnosis and treatment
GA ID:
GA353550
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
24-Aug-2023
Publish Date:
22-Jan-2024
Category:
Medical Research
Grant Term:
1-Jan-2024 to 31-Dec-2028
Value (AUD):
$597,020.96
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 22/23 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Exploiting long noncoding RNAs for lung cancer diagnosis and treatment
Purpose:
Cancer cells exploit a newly discovered class of molecules for their growth and resistance to treatment. This research program will develop a better understanding of how these molecules influence lung cancer initiation and treatment response. It will also uncover new biomarkers that reveal the presence of lung cancer, as well as new molecular targets for anti-cancer drugs. Findings from this research will pave the way towards earlier detection of lung cancer and more effective cancer treatments.
GO ID:
GO Title:
Investigator Grants 2023
Internal Reference ID:
2023/GNT2026530
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The University of Newcastle
Recipient ABN:
15 736 576 735
Grant Recipient Location
Suburb:
Callaghan
Town/City:
Callaghan
Postcode:
2308
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA